Method for separating and purifying cobra venom neurotoxin with combination of ion exchange and reverse phase chromatography
An ion-exchange chromatography, separation and purification technology, applied in the field of biopharmaceuticals, can solve the problems of long separation and purification cycle and complicated operation steps, and achieve the effect of simplifying the separation and purification steps, high purity and high yield
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] The separation and purification method of cobra venom neurotoxin of the present embodiment comprises the following steps:
[0037] (1) The cobra venom crude product solution of 0.10g / mL is centrifuged, and a 0.45 μm microporous membrane is used to filter to obtain the test solution A, which is set aside.
[0038] (2) said need testing solution A is purified by ion exchange chromatography, the medium of said ion exchange chromatography is CM Sepharose Fast Flow, with 10mM NaH 2 PO 3 The buffer was mobile phase A to include 10 mM NaH with 1 M NaCl 2 PO 3 The buffer is mobile phase B. Before gradient elution, use 2 column bed volumes of mobile phase B for activation elution, then use 3 column bed volumes of mobile phase A for equilibrium elution; then perform gradient elution, the steps of gradient elution are: A : B volume ratio is 100%: 0%, A: B volume ratio is 90%: 10%, A: B volume ratio is 85%: 15%, A: B volume ratio is 40%: 60%, HPLC detection, Collect, get need ...
Embodiment 2
[0042] The separation and purification method of cobra venom neurotoxin of the present embodiment comprises the following steps:
[0043] (1) The cobra venom crude product solution of 0.05g / mL is centrifuged, and a 0.45 μm microporous membrane is used to filter to obtain the test solution A, which is set aside.
[0044] (2) said need testing solution A is purified by ion exchange chromatography, the medium of said ion exchange chromatography is CM Sepharose Fast Flow, with 8mM NaH 2 PO 3 The buffer was mobile phase A to include 1M NaCl in 8mM NaH 2 PO 3 The buffer is mobile phase B. Before gradient elution, use 1 column bed volume of mobile phase B for activation elution, then use 2 column bed volumes of mobile phase A for equilibrium elution, and then perform gradient elution. The steps of gradient elution are: A : B volume ratio is 100%: 0%, A: B volume ratio is 90%: 10%, A: B volume ratio is 85%: 15%, A: B volume ratio is 40%: 60%, HPLC detection, Collected to obtain the...
Embodiment 3
[0048] The separation and purification method of cobra venom neurotoxin of the present embodiment comprises the following steps:
[0049] (1) The cobra venom crude product solution of 0.15g / mL is centrifuged, and a 0.45 μm microporous membrane is used to filter to obtain the test solution A, which is set aside.
[0050] (2) said need testing solution A is purified by ion exchange chromatography, the medium of said ion exchange chromatography is CM Sepharose Fast Flow, with 12mM NaH 2 PO 3 The buffer was mobile phase A to include 12 mM NaH with 1M NaCl 2 PO 3 The buffer is mobile phase B. Before gradient elution, use 3 column bed volumes of mobile phase B for activation elution, then use 4 column bed volumes of mobile phase A for equilibrium elution, gradient elution, the steps of gradient elution are: A:B The volume ratio is 100%:0%, A:B volume ratio is 90%:10%, A:B volume ratio is 85%:15%, A:B volume ratio is 40%:60%, HPLC detection, collection, Need testing solution B, ...
PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com